$10.23
5.19%
Nasdaq, Apr 21, 08:17 pm CET
ISIN
US30052C1071
Symbol
EOLS
Sector
Industry

Evolus, Inc. Stock price

$10.79
-2.80 20.60% 1M
-5.84 35.12% 6M
-0.25 2.26% YTD
-0.85 7.30% 1Y
-0.12 1.10% 3Y
+6.36 143.57% 5Y
-0.71 6.17% 10Y
Nasdaq, Closing price Thu, Apr 17 2025
+0.68 6.73%
ISIN
US30052C1071
Symbol
EOLS
Sector
Industry

Key metrics

Market capitalization $686.10m
Enterprise Value $729.13m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.74
P/S ratio (TTM) P/S ratio 2.58
P/B ratio (TTM) P/B ratio 124.08
Revenue growth (TTM) Revenue growth 31.76%
Revenue (TTM) Revenue $266.27m
EBIT (operating result TTM) EBIT $-30.19m
Free Cash Flow (TTM) Free Cash Flow $-19.47m
Cash position $86.95m
EPS (TTM) EPS $-0.81
P/E forward negative
P/S forward 1.96
EV/Sales forward 2.08
Short interest 11.49%
Show more

Is Evolus, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Evolus, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Evolus, Inc. forecast:

7x Buy
100%

Analyst Opinions

7 Analysts have issued a Evolus, Inc. forecast:

Buy
100%

Financial data from Evolus, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
266 266
32% 32%
100%
- Direct Costs 89 89
34% 34%
34%
177 177
31% 31%
66%
- Selling and Administrative Expenses 192 192
21% 21%
72%
- Research and Development Expense 9.17 9.17
40% 40%
3%
-24 -24
20% 20%
-9%
- Depreciation and Amortization 5.87 5.87
0% 0%
2%
EBIT (Operating Income) EBIT -30 -30
16% 16%
-11%
Net Profit -50 -50
18% 18%
-19%

In millions USD.

Don't miss a Thing! We will send you all news about Evolus, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evolus, Inc. Stock News

Neutral
Business Wire
3 days ago
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant in April of an aggregate of 30,579 restricted stock units (RSUs) of the company's common stock to 13 newly hired non-executive employees of the company. The awards were approved by the compensation committe...
Neutral
Business Wire
5 days ago
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced the commercial launch date for Evolysse™ Form and Evolysse™ Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse™ collection, scheduled for Friday, April 18th. To support the introduction, Evolus will in...
Neutral
Business Wire
6 days ago
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced the launch of its bold new campaign, “Drop the F Word,” ahead of the upcoming commercial launch of Evolysse™. Designed to challenge outdated perceptions and language in the aesthetics industry, the campaign introduces Evolysse™, a col...
More Evolus, Inc. News

Company Profile

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November, 2012 and is headquartered in Newport Beach, CA.

Head office United States
CEO David Moatazedi
Employees 332
Founded 2012
Website www.evolus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today